Mirum Pharmaceuticals (mirm 4 05/01/29)
13F holders, Q4 2025 (December 31)5holders −1
2new positions
3sold out
$2.58avg. 13F price*
At the end of Q4 2025, 5 institutions reported holding Mirum Pharmaceuticals (mirm 4 05/01/29) in their 13F filings, down 1 from Q3 2025. 2 opened new positions and 3 sold out. The largest holders were Sei Investments Co. ($588K), Oppenheimer Asset Management Inc. ($165K) and Stephens Inc. ($52K).
- Company
- Mirum Pharmaceuticals (mirm 4 05/01/29)
- CUSIP
- 604749AB7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $31K |
| Exits | 3 | $7.3M |
All 13F filers, Q3 2025 → Q4 2025: 12,000 shares bought and 200,341 shares sold, net −188,341 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Sei Investments Co. | 0.00% | No change | 228,000 | $588K |
| Oppenheimer Asset Management Inc. | 0.00% | No change | 64,000 | $165K |
| Stephens Inc. | 0.00% | No change | 20,000 | $52K |
| NewEdge Advisors, LLC | 0.00% | New | 10,000 | $26K |
| CoreCap Advisors, LLC | 0.00% | New | 2,000 | $5K |
"% of holder's portfolio" is MIRUM PHARMACEUTICALS (MIRM 4 05/01/29)'s weight in each manager's 13F, not the share of Mirum Pharmaceuticals (mirm 4 05/01/29) the manager owns.